NCT06358456View on ClinicalTrials.gov

Influence of Artificial Tears on Keratometry and Biometry Measurements With Different Devices

NACompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

April 22, 2022

Study Completion Date

April 22, 2022

Conditions
Healthy
Interventions
DRUG

Artificial tear

Application of low viscosity artificial tears (Artelac EDO). The active ingredient is hypromellose (1.92 mg per 0.6 ml container).

OTHER

No artificial tears

Before artificial tear application, 2 baseline measurements were taken of the cornea without any intervention

Trial Locations (1)

60590

Goethe University Hospital, Frankfurt am Main

All Listed Sponsors
lead

University Clinic Frankfurt

OTHER

NCT06358456 - Influence of Artificial Tears on Keratometry and Biometry Measurements With Different Devices | Biotech Hunter | Biotech Hunter